Using a test to choose treatment for sarcoma or melanoma
Part of Cancer, Skin clinical trials.
This study uses QPOP to predict which treatment may work best for people with sarcoma or melanoma. It mainly needs tumor samples from a new biopsy or surgery so researchers can run the test and compare results to treatment choices.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with sarcoma or melanoma
- You have at least one tumor spot that can be biopsied or removed (fresh sample)
- You (or your legal representative) can sign an informed consent form
- You can follow the study’s visits and procedures as required
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a way to use patient information to help doctors decide which treatment approach may fit best for people with certain bone or soft-tissue tumors. It may help improve selection and care planning, but it depends on whether your data can be used.
This trial tests a new drug (TQB2916) combined with either chemotherapy or another immunotherapy (penpulimab) for advanced soft tissue sarcomas or melanoma. It aims to see if the combination shrinks tumors or slows cancer growth.
This trial is testing a new way to predict which immunotherapy might work best for your cancer. It uses a sample of your tumor to look for personal markers, so your treatment can be tailored to you.
This study tests the genes of your cancer to learn more about advanced breast, lung, melanoma, or sarcoma tumors. It may help doctors find better ways to treat these cancers in the future.
This trial uses a new testing platform to analyze the genes and proteins in your tumor, aiming to find the most effective treatments for people with cancer that has come back, is not responding to treatment, or has spread. It is designed for both children and adults with any type of blood cancer or solid tumor.
This study is for people who have been diagnosed with bone or soft tissue sarcoma confirmed by a tissue test. It may help researchers understand sarcoma better, but you must be able to understand and consent to take part.
Hear when a new Sarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.